-
Kashyap Patel, MD, Sees Link Between COVID-19 and Cancer Progression, Calls for More Biomarker Testing
(Hinzugefügt: 10.04.2023 um 14:35 Uhr)
https://www.ajmc.com/view/kashyap-patel-md-sees-link-between-covid-19-and-cancer-progression-calls-for-more-biomarker-testing
-
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
(Hinzugefügt: 08.06.2022 um 10:03 Uhr)
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00273-X/fulltext
-
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study
(Hinzugefügt: 27.05.2022 um 08:04 Uhr)
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00202-9/fulltext
-
Jüngeres Alter bei Krebspatienten mit erhöhtem Sterberisiko bei COVID-19 assoziiert
(Hinzugefügt: 13.05.2022 um 07:36 Uhr)
https://www.aerzteblatt.de/nachrichten/134032/Juengeres-Alter-bei-Krebspatienten-mit-erhoehtem-Sterberisiko-bei-COVID-19-assoziiert
-
Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area
(Hinzugefügt: 30.04.2022 um 11:09 Uhr)
https://www.mdpi.com/2072-6694/14/9/2209/htm
-
Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy
(Hinzugefügt: 27.04.2022 um 10:01 Uhr)
https://journals.lww.com/pidj/fulltext/9900/recurrent_sars_cov_2_infection_and_impaired.56.aspx
-
Shedding of SARS-CoV-2 for 85 Days in COVID-19 Patients With Type 2 Diabetes Mellitus and Lung Metastasis: A Case Report
(Hinzugefügt: 03.04.2022 um 18:11 Uhr)
https://www.frontiersin.org/articles/10.3389/fmed.2022.828819/full
-
COVID-19 für Krebspatienten weiter sehr gefährlich
(Hinzugefügt: 27.03.2022 um 08:16 Uhr)
https://www.aerzteblatt.de/nachrichten/132785/COVID-19-fuer-Krebspatienten-weiter-sehr-gefaehrlich
-
COVID-19 bei Krebspatient*innen schützen – testen – frühzeitig behandeln
(Hinzugefügt: 27.03.2022 um 08:16 Uhr)
https://www.dgho.de/publikationen/stellungnahmen/gute-aerztliche-praxis/coronavirus/covid-19-20220321-final.pdf
-
COVID-19: Krebsimmuntherapie führt zu milderen Verläufen
(Hinzugefügt: 23.02.2022 um 11:45 Uhr)
https://www.aerzteblatt.de/nachrichten/132000/COVID-19-Krebsimmuntherapie-fuehrt-zu-milderen-Verlaeufen
-
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19
(Hinzugefügt: 23.02.2022 um 11:45 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789152
-
Coronavirus-Infektion (COVID-19) bei Patient*innen mit Blut- und Krebserkrankungen
(Hinzugefügt: 14.02.2022 um 16:16 Uhr)
https://www.onkopedia.com/de/onkopedia/guidelines/coronavirus-infektion-covid-19-bei-patient-innen-mit-blut-und-krebserkrankungen/@@guideline/html/index.html
-
COVID-19 Vaccination and Breakthrough Infections in Patients with Cancer
(Hinzugefügt: 26.12.2021 um 10:41 Uhr)
https://www.annalsofoncology.org/article/S0923-7534(21)04880-8/fulltext
-
COVID-19 and human papillomavirus: Paradoxical immunity
(Hinzugefügt: 21.11.2021 um 08:17 Uhr)
https://onlinelibrary.wiley.com/doi/10.1111/jocd.14022
-
Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
(Hinzugefügt: 15.11.2021 um 07:16 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2786026
-
Special Considerations in Adults and Children With Cancer
(Hinzugefügt: 09.11.2021 um 15:43 Uhr)
https://www.covid19treatmentguidelines.nih.gov/special-populations/cancer/
-
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
(Hinzugefügt: 05.11.2021 um 07:49 Uhr)
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00573-8/fulltext
-
Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer
(Hinzugefügt: 04.11.2021 um 08:31 Uhr)
https://jamanetwork.com/journals/jamaoncology/fullarticle/2785677
-
Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
(Hinzugefügt: 30.10.2021 um 14:09 Uhr)
https://www.medrxiv.org/content/10.1101/2021.10.29.21265511v1
-
EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
(Hinzugefügt: 30.10.2021 um 12:01 Uhr)
https://journals.lww.com/hemasphere/Fulltext/2021/07000/EPICOVIDEHA__A_Ready_to_Use_Platform_for.12.aspx
-
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
(Hinzugefügt: 30.10.2021 um 12:00 Uhr)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515781/
-
Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C)
(Hinzugefügt: 30.10.2021 um 11:58 Uhr)
https://ascopubs.org/doi/full/10.1200/JCO.21.01074
-
Coronavirus-Infektion (COVID-19) bei Patient*innen mit Blut- und Krebserkrankungen
(Hinzugefügt: 18.10.2021 um 09:52 Uhr)
https://www.onkopedia.com/de/onkopedia/guidelines/coronavirus-infektion-covid-19-bei-patient-innen-mit-blut-und-krebserkrankungen/@@guideline/html/index.html
-
Long COVID ist bei Tumorpatienten häufiger und mit erhöhter Mortalität assoziiert
(Hinzugefügt: 22.09.2021 um 10:32 Uhr)
https://www.aerzteblatt.de/nachrichten/127299/Long-COVID-ist-bei-Tumorpatienten-haeufiger-und-mit-erhoehter-Mortalitaet-assoziiert
-
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study
(Hinzugefügt: 28.08.2021 um 17:03 Uhr)
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00454-X/fulltext
-
COVID-19-Infektionen bei Lymphom-Patienten: Häufiger persistierende Symptomlast
(Hinzugefügt: 20.06.2021 um 17:16 Uhr)
https://www.aerzteblatt.de/nachrichten/124710/COVID-19-Infektionen-bei-Lymphom-Patienten-Haeufiger-persistierende-Symptomlast
-
Articleshttps://doi.org/10.1038/s41591-021-01386-71Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 2Abramson Cancer Center, University of Pennsylvania, Philadelphia, P
(Hinzugefügt: 25.05.2021 um 14:03 Uhr)
https://www.nature.com/articles/s41591-021-01386-7.epdf?sharing_token=H0qcJ41HMWP0IKSTmhiWqdRgN0jAjWel9jnR3ZoTv0MXrr8TQM4wwmkmdHNMvaILwf2KR3oBX4OPSrUUYKBDDBxCGQAkUlRpysYHiyaGx72_zSZVo-LqsQsTcy3yIKDZ4km0J8OPo6virM--yKq1q-UNnA7kXr5-mvTCpRhSn34%3D
-
Projecting COVID-19 disease severity in cancer patients using purposefully-designed machine learning
(Hinzugefügt: 04.05.2021 um 05:27 Uhr)
https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06038-2
-
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the “flare phenomenon” to the “abscopal effect”
(Hinzugefügt: 02.05.2021 um 02:53 Uhr)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913037/
-
Experten sehen Versorgung von Krebspatienten in Gefahr
(Hinzugefügt: 20.04.2021 um 05:53 Uhr)
https://www.aerzteblatt.de/nachrichten/123070/Experten-sehen-Versorgung-von-Krebspatienten-in-Gefahr
-
Krebspatient durch Corona geheilt?
(Hinzugefügt: 18.04.2021 um 17:08 Uhr)
https://www.praxisvita.de/corona-und-krebs-Hodgkin-Lymphon-durch-covid-19-geheilt-19762.html
-
Impact of COVID-19 on Gynaecological oncology; a global perspective
(Hinzugefügt: 06.04.2021 um 06:39 Uhr)
https://www.cell.com/heliyon/fulltext/S2405-8440(21)00761-1
-
Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials
(Hinzugefügt: 01.04.2021 um 19:11 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777836
-
COVID-19 and cancer: 1 year on
(Hinzugefügt: 30.03.2021 um 19:21 Uhr)
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00148-0/fulltext
-
Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study
(Hinzugefügt: 25.03.2021 um 06:49 Uhr)
https://www.medrxiv.org/content/10.1101/2021.03.18.21253778v1
-
COVID-19 More Deadly with Blood than Solid Cancer: Study
(Hinzugefügt: 17.02.2021 um 14:48 Uhr)
https://www.the-scientist.com/news-opinion/covid-19-more-deadly-with-blood-than-solid-cancer-study-68459
-
COVID-19 More Deadly with Blood than Solid Cancer: Study
(Hinzugefügt: 17.02.2021 um 14:48 Uhr)
https://www.the-scientist.com/news-opinion/covid-19-more-deadly-with-blood-than-solid-cancer-study-68459
-
COVID-19 More Deadly with Blood than Solid Cancer: Study
(Hinzugefügt: 17.02.2021 um 14:48 Uhr)
https://www.the-scientist.com/news-opinion/covid-19-more-deadly-with-blood-than-solid-cancer-study-68459
-
Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19
(Hinzugefügt: 06.02.2021 um 08:55 Uhr)
https://www.medrxiv.org/content/10.1101/2021.02.05.21250953v1
-
Inflammatory leptomeningeal cytokines mediate COVID-19 neurologic symptoms in cancer patients
(Hinzugefügt: 20.01.2021 um 08:12 Uhr)
https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00051-9
-
SARS‐CoV‐2‐induced remission of Hodgkin lymphoma
(Hinzugefügt: 10.01.2021 um 19:31 Uhr)
https://onlinelibrary.wiley.com/doi/10.1111/bjh.17116
-
313 COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality
(Hinzugefügt: 29.12.2020 um 09:31 Uhr)
https://ash.confex.com/ash/2020/webprogram/Paper138611.html
-
Adaptive immunity to SARS-CoV-2 in cancer patients: The CAPTURE study
(Hinzugefügt: 25.12.2020 um 08:09 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.21.20248608v1
-
FDA Oncology Center of Excellence During COVID-19—Working for Patients With Cancer
(Hinzugefügt: 24.12.2020 um 08:49 Uhr)
https://jamanetwork.com/journals/jamaoncology/fullarticle/2774311
-
Obinutuzumab/rituximab Decreased platelet count and chronic COVID-19 pneumonia: case report
(Hinzugefügt: 23.12.2020 um 20:51 Uhr)
https://link.springer.com/article/10.1007/s40278-020-87403-5
-
The “New Normal” of Cancer Treatment Delays Is Nothing New
(Hinzugefügt: 19.12.2020 um 09:18 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2774095
-
Assessment of Time-to-Treatment Initiation and Survival in a Cohort of Patients With Common Cancers
(Hinzugefügt: 19.12.2020 um 09:17 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2774101
-
COVID-19 and Social Distancing Efforts—Implications for Cancer Control
(Hinzugefügt: 19.12.2020 um 09:09 Uhr)
https://jamanetwork.com/journals/jamaoncology/fullarticle/2773841
-
Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy
(Hinzugefügt: 19.12.2020 um 09:09 Uhr)
https://jamanetwork.com/journals/jamaoncology/fullarticle/2773836
-
Experten warnen vor bedrohlicher Situation für Krebspatienten durch Corona
(Hinzugefügt: 15.12.2020 um 09:48 Uhr)
https://www.aerzteblatt.de/nachrichten/119347/Experten-warnen-vor-bedrohlicher-Situation-fuer-Krebspatienten-durch-Corona
-
How Will Patients With Cancer Fare During COVID-19?
(Hinzugefügt: 05.12.2020 um 08:25 Uhr)
https://jamanetwork.com/journals/jamaoncology/fullarticle/2773379
-
COVID-19 in patients with cancer
(Hinzugefügt: 01.12.2020 um 08:29 Uhr)
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30668-9/fulltext
-
COVID: Asymptomatic Cancer Patient Was A One-Woman Super-Spreader
(Hinzugefügt: 27.11.2020 um 11:16 Uhr)
https://www.acsh.org/news/2020/11/24/covid-asymptomatic-cancer-patient-was-one-woman-super-spreader-15176
-
Perceived Care and Well-being of Patients With Cancer and Matched Norm Participants in the COVID-19 Crisis
(Hinzugefügt: 27.11.2020 um 10:50 Uhr)
https://jamanetwork.com/journals/jamaoncology/fullarticle/2773449
-
Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy
(Hinzugefügt: 07.11.2020 um 08:00 Uhr)
https://jamanetwork.com/journals/jamaoncology/fullarticle/2772789
-
Cancer Care Disparities during the COVID-19 Pandemic
(Hinzugefügt: 03.11.2020 um 20:34 Uhr)
https://www.cell.com/action/showPdf?pii=S1535-6108%2820%2930554-7
-
Patients with cancer and the effect of primary tumor subtype
(Hinzugefügt: 03.11.2020 um 19:37 Uhr)
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30442-3/fulltext
-
falsch negative PCR Testergebnisse
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.nature.com/articles/s41409-020-0972-8
-
"Coronavirus-Infektion (COVID-19) bei Patienten mit Blut- und Krebserkrankungen"
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.awmf.org/leitlinien/detail/ll/018-037.html
-
cancer
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.cell.com/cell/fulltext/S0092-8674(20)31146-6?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867420311466%3Fshowall%3Dtrue